Orforglipron UK Launch: Availability, Price and What to Expect

The UK weight-loss treatment market has taken another significant step forward with the arrival of Orforglipron, a once-daily GLP-1 weight-loss tablet.

On 10 August 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) authorised Orforglipron for weight management and type 2 diabetes, making the UK the first country in Europe to approve the treatment.

For people who want the appetite-control benefits associated with GLP-1 medicines but would rather avoid injections, Orforglipron provides an important new option.

Unlike Wegovy® and Mounjaro®, which are administered by injection, Orforglipron is taken as a once-daily tablet. It can also be taken with or without food or water, removing some of the administration restrictions associated with other oral GLP-1 medicines.

Orforglipron is now listed by 24 HR Pharmacy, with prices currently starting from £85.

In this guide, we explain the Orforglipron UK launch, availability, price, eligibility, dosing schedule and what patients can expect from treatment.

Is Orforglipron Approved in the UK?

Yes.

The MHRA officially authorised Orforglipron on 10 August 2026.

The medicine is authorised for weight loss and weight maintenance alongside a reduced-calorie diet and increased physical activity in eligible adults.

The approval made the UK the first European country to authorise the oral GLP-1 treatment.

This represents an important development because most of the best-known GLP-1 weight-management treatments have traditionally been injectable medicines.

What Is Orforglipron?

Orforglipron is an oral GLP-1 receptor agonist developed by Eli Lilly.

GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone involved in regulating:

• appetite;

• feelings of fullness;

• food intake;

• digestion;

• and blood glucose.

Orforglipron activates GLP-1 receptors in the body, helping reduce hunger and making people feel satisfied after eating smaller amounts of food.

This can make it easier to maintain the calorie deficit needed for weight loss.

What Makes Orforglipron Different?

One of the biggest differences is that Orforglipron is a small, non-peptide molecule.

Many existing GLP-1 medicines are peptide-based. These molecules can be broken down by the digestive system, which is one reason treatments such as Wegovy and Mounjaro are commonly administered as injections.

Orforglipron's chemistry allows it to be taken as a conventional tablet.

According to the current 24 HR Pharmacy instructions, Orforglipron can be taken:

• once daily;

• at any time of day;

• with or without food;

• and with or without water.

For patients who dislike injections, this could make GLP-1 treatment considerably easier to incorporate into everyday life.

Is Orforglipron Available in the UK Now?

Yes.

Following MHRA approval in August 2026, Orforglipron is now available through regulated UK pharmacy services, subject to clinical eligibility and prescription.

24 HR Pharmacy currently lists Orforglipron as an MHRA-approved treatment and offers the starting 0.8 mg strength for pre-order alongside the other available strengths.

Because Orforglipron is a prescription medicine, availability does not mean it can simply be purchased without assessment.

A qualified prescriber must determine that it is appropriate for you.

How Much Does Orforglipron Cost in the UK?

The current 24 HR Pharmacy Orforglipron price starts from £85 for a 30-tablet pack.

Prices may vary depending on the strength prescribed and may change over time, so patients should check the treatment page for the latest price before ordering.

The available strengths currently listed by 24 HR Pharmacy are:

• 0.8 mg

• 2.5 mg

• 5.5 mg

• 9 mg

• 14.5 mg

• 17.2 mg

Each pack contains 30 tablets, corresponding to approximately one month of once-daily treatment.

Why Could Orforglipron Price Be Important?

Cost is an important consideration with long-term weight-management medication.

Treatment is generally measured in months rather than days, meaning patients need to consider the ongoing cost rather than simply the price of their first pack.

Orforglipron may also compete with established private weight-loss treatments such as:

• Wegovy injection;

• Wegovy pill;

• and Mounjaro.

Price should not be the only factor when deciding between them.

Patients should also consider:

• expected effectiveness;

• side effects;

• eligibility;

• medical history;

• daily tablets versus weekly injections;

• convenience;

• and how easily they can follow the treatment schedule.

The cheapest treatment is not necessarily the most appropriate one.

Who Can Get Orforglipron in the UK?

The MHRA has authorised Orforglipron for weight loss and weight maintenance in adults with:

• a BMI of 30 kg/m² or above; or

• a BMI between 27 and 30 kg/m² with at least one weight-related health condition.

Weight-related conditions may include problems such as:

• type 2 diabetes;

• high blood pressure;

• high cholesterol;

• or obstructive sleep apnoea.

Final eligibility depends on a clinical assessment.

BMI alone does not automatically mean treatment will be approved.

Can You Buy Orforglipron Online in the UK?

Orforglipron can be accessed online through a regulated prescribing and pharmacy service such as 24 HR Pharmacy, but it is not an over-the-counter medicine.

You will need to complete a clinical assessment before treatment can be supplied.

A prescriber may consider:

• your BMI;

• medical conditions;

• current medicines;

• previous weight-loss treatments;

• previous GLP-1 use;

• side effects;

• pregnancy or breastfeeding;

• and other relevant health risks.

Only after this information has been reviewed can Orforglipron be prescribed where clinically appropriate.

What Is the Orforglipron Dosing Schedule?

Orforglipron treatment does not begin at the maximum dose.

According to the current dosing information published by 24 HR Pharmacy, the dose is gradually increased:

The current maximum dose is 17.2 mg once daily.

Dose increases should take place no more frequently than every 30 days and only where the current dose is being tolerated.

Why Does Orforglipron Start at 0.8 mg?

Starting at a low dose gives the body time to adapt to the medication.

Like other GLP-1 medicines, Orforglipron can cause gastrointestinal side effects, particularly:

• nausea;

• diarrhoea;

• constipation;

• vomiting;

• indigestion;

• and abdominal discomfort.

Starting immediately at a higher dose could make these effects more difficult to tolerate.

The gradual 0.8 mg → 2.5 mg → 5.5 mg escalation therefore helps introduce the medicine more slowly before progressing to an appropriate maintenance dose.

Does Everyone Reach 17.2 mg?

No.

The goal of treatment is not to reach the maximum dose as quickly as possible.

Current 24 HR Pharmacy information lists maintenance doses of:

• 9 mg once daily

• 14.5 mg once daily

• 17.2 mg once daily

The appropriate maintenance dose depends on factors such as:

• appetite control;

• weight-loss response;

• side effects;

• and overall tolerability.

If side effects become troublesome, your prescriber may recommend remaining at a particular dose for longer before considering an increase.

Patients should never increase the dose independently.

How Do You Take Orforglipron?

Orforglipron is designed to be straightforward to use.

The current 24 HR Pharmacy directions state that patients take one tablet once daily.

It can be taken:

• morning, afternoon or evening;

• with food;

• without food;

• with water;

• or without water.

The tablet should be swallowed whole.

This flexibility is one of the treatment's main advantages.

Orforglipron vs Wegovy Pill

Both medicines offer an oral alternative to injectable GLP-1 treatments, but there is an important difference.

The Wegovy pill contains oral semaglutide, a peptide-based GLP-1 medicine.

Its absorption requires a more structured administration routine.

Orforglipron is a non-peptide small molecule and can be taken with or without food or water.

This could make Orforglipron particularly attractive for people who find fasting requirements inconvenient.

Orforglipron vs Weight Loss Injections

The most obvious difference is administration.

Orforglipron

• Tablet

• Taken every day

• No injection

• Can be taken with or without food

• Flexible time of day

Wegovy and Mounjaro

• Injection pens

• Generally administered once weekly

• No daily tablet to remember

Some patients may prefer taking one tablet each day.

Others may find one injection per week more convenient.

Treatment preference should therefore form part of the prescribing discussion.

How Much Weight Could You Lose With Orforglipron?

Clinical trials have shown that Orforglipron can produce clinically meaningful weight loss when combined with lifestyle changes.

However, the amount of weight lost varies considerably between individuals.

Results depend on factors including:

• starting weight;

• maintenance dose;

• treatment adherence;

• diet;

• physical activity;

• side effects;

• and individual response.

Patients should avoid treating clinical-trial averages as a guaranteed personal result.

What Side Effects Should You Expect?

As with other GLP-1 treatments, the most frequently reported Orforglipron side effects are gastrointestinal.

These include:

• nausea;

• diarrhoea;

• constipation;

• vomiting;

• indigestion;

• and reduced appetite.

24 HR Pharmacy notes that these were generally mild to moderate during clinical trials and were more common at higher doses.

Gradual dose escalation is therefore an important part of treatment.

What Happens If You Miss an Orforglipron Tablet?

According to the current 24 HR Pharmacy instructions, if you remember the missed dose later on the same day, you can take it then.

If the day has already passed, skip the missed dose and continue the following day.

Do not take a double dose to compensate.

Can You Switch From Wegovy or Mounjaro to Orforglipron?

Potentially.

24 HR Pharmacy states that patients may be able to switch from another weight-management medicine to Orforglipron.

However, the correct timing and starting dose depend on:

• your current treatment;

• current dose;

• previous side effects;

• treatment history;

• and when your last dose was taken.

Your prescriber should provide a personalised switching plan.

Do not overlap GLP-1 treatments independently.

Can You Take Orforglipron With Another GLP-1?

Orforglipron should not be combined with another GLP-1 receptor agonist medicine, according to the current 24 HR Pharmacy directions.

If you are currently taking another GLP-1 medicine and want to change treatments, discuss the switch with your prescriber.

What Should Patients Expect When Starting Orforglipron?

The First Month

Treatment begins at 0.8 mg once daily.

The main purpose of this stage is to introduce the medicine gradually.

Some people may begin noticing:

• reduced hunger;

• feeling full sooner;

• less interest in snacking;

• or easier portion control.

Others may notice little change initially.

Both experiences can occur.

Months Two and Three

Where appropriate, treatment progresses to:

• 2.5 mg once daily;

• followed by 5.5 mg once daily.

Appetite effects may become more noticeable as treatment progresses.

Maintenance Treatment

After the initial escalation stages, the prescriber may recommend:

• 9 mg;

• 14.5 mg;

• or up to 17.2 mg once daily.

The appropriate dose depends on response and tolerability.

Will Orforglipron Replace Wegovy or Mounjaro?

Probably not.

Rather than replacing existing medicines, Orforglipron adds another treatment option.

Different patients prioritise different things.

Someone may choose Orforglipron because they:

• dislike needles;

• want a tablet;

• travel frequently;

• want flexible administration;

• or have struggled with other treatment routines.

Another person may prefer Mounjaro or Wegovy because a once-weekly injection is more convenient than remembering a tablet every day.

Having more treatment options allows prescribing to become more personalised.

Will Orforglipron Be Available on the NHS?

MHRA approval and NHS availability are two separate things.

MHRA authorisation means the medicine has been approved for use in the UK for its licensed indications.

It does not automatically mean Orforglipron will immediately be routinely available through the NHS.

NHS access can depend on factors such as NICE assessment, commissioning arrangements, clinical eligibility criteria and availability.

Patients looking for immediate access may therefore consider regulated private prescribing services where clinically appropriate.

Why the Orforglipron UK Launch Matters

The arrival of Orforglipron could significantly broaden the range of GLP-1 weight-management options available to UK patients.

Until recently, someone wanting powerful GLP-1-based obesity treatment generally had to choose between injectable medicines or oral medicines with more restrictive administration requirements.

Orforglipron offers:

• oral administration;

• once-daily dosing;

• no injection;

• no fasting requirement;

• flexible timing;

• and multiple maintenance doses.

The UK becoming the first European country to authorise the medicine also represents an important milestone for the rapidly developing obesity-treatment market.

How 24 HR Pharmacy Can Help

24 HR Pharmacy currently lists Orforglipron from £85, with 30-tablet packs and strengths ranging from 0.8 mg to 17.2 mg.

Treatment is accessed through a clinician-led prescribing pathway.

Online Consultation

Patients begin by completing a confidential online health assessment.

This allows the clinical team to review factors such as:

• height;

• weight;

• BMI;

• medical history;

• current medicines;

• weight-related health conditions;

• and previous weight-loss treatment.

Prescriber Assessment

A qualified prescriber reviews whether Orforglipron is clinically appropriate.

Meeting the BMI criteria does not automatically guarantee a prescription.

Safety and individual suitability come first.

Personalised Dosing

Eligible patients generally begin at 0.8 mg once daily before gradually progressing through the dose-escalation schedule.

The prescriber can assess whether each increase is appropriate and whether a patient should remain on their existing dose for longer.

Switching Support

Patients already using another weight-loss treatment may be able to switch to Orforglipron.

24 HR Pharmacy's prescribers can review the existing treatment and advise on an appropriate starting point and switching schedule.

Ongoing Support

Patients can also receive guidance around:

• side effects;

• dose escalation;

• treatment response;

• medication use;

• and sustainable weight-management habits.

The aim is not simply to provide tablets, but to help patients use prescription weight-management treatment appropriately and safely.

Frequently Asked Questions

Is Orforglipron available in the UK?

Yes. The MHRA authorised Orforglipron on 10 August 2026, making the UK the first European country to approve it.

Can I buy Orforglipron from 24 HR Pharmacy?

24 HR Pharmacy currently lists Orforglipron as an MHRA-approved prescription weight-management treatment, subject to clinical assessment and approval by a prescriber.

How much does Orforglipron cost in the UK?

24 HR Pharmacy currently lists Orforglipron from £85. Prices can vary by strength and may change, so check the treatment page for the latest price.

What is the starting Orforglipron dose?

The current 24 HR Pharmacy schedule starts at 0.8 mg once daily for at least 30 days.

What is the maximum Orforglipron dose?

The current maximum dose is 17.2 mg once daily.

Do I need to take Orforglipron on an empty stomach?

No. Orforglipron can be taken at any time of day, with or without food or water.

Who is eligible?

The MHRA has authorised it for weight management in adults with a BMI of at least 30, or a BMI between 27 and 30 with at least one weight-related comorbidity, alongside reduced-calorie eating and increased physical activity.

Is Orforglipron available on the NHS?

MHRA approval does not automatically mean routine NHS availability. NHS access depends on separate assessment and commissioning decisions.

Is Orforglipron an injection?

No. Orforglipron is a once-daily tablet.

Can I switch from Mounjaro to Orforglipron?

Potentially, but the appropriate timing and starting dose must be determined by your prescriber based on your existing treatment.

Final Thoughts

The Orforglipron UK launch represents an important new chapter in prescription weight management.

The MHRA officially authorised Orforglipron on 10 August 2026, making the UK the first country in Europe to approve the once-daily GLP-1 tablet for weight management and type 2 diabetes.

For weight management, it is authorised for eligible adults with obesity or overweight accompanied by a relevant weight-related health condition.

Its main practical advantage is straightforward: GLP-1 treatment without injections or a complicated fasting routine.

Orforglipron can be taken once daily, at any time, with or without food or water.

At 24 HR Pharmacy, Orforglipron is currently listed from £85, with strengths of 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg.

Treatment begins at 0.8 mg once daily and is gradually increased, with at least 30 days between dose increases. The maximum listed dose is 17.2 mg daily.

For patients who have previously avoided GLP-1 medicines because they dislike injections, or who want greater flexibility from an oral treatment, Orforglipron could provide an important new option.

Through 24 HR Pharmacy's clinician-led weight-management service, eligible patients can complete an assessment, have their suitability reviewed by a prescriber and receive personalised guidance around dosing, side effects, switching treatments and ongoing weight management.